Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Effective Drug Delivery Systems
4.2.2 Increasing Investments for Pharmaceutical Developments
4.3 Market Restraints
4.3.1 Availability of Substitute Drugs
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Oral Thin Film
5.1.2 Transdermal Thin Film
5.2 By Indication
5.2.1 Schizophrenia
5.2.2 Migraine
5.2.3 Opioid Dependence
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ZIM Laboratories Limited
6.1.2 Aquestive Therapeutics
6.1.3 Indivior PLC
6.1.4 Tesa Labtec GmbH
6.1.5 Pfizer, Inc.
6.1.6 ARx, LLC.
6.1.7 Solvay
6.1.8 AdhexPharma
6.1.9 INTELGENX CORP


7 MARKET OPPORTUNITIES AND FUTURE TRENDS